AMIGO2通过诱导类似于癌症干细胞的表型来加速瘤的进展
Hee Kyung Seong1, Mitsuhiko Osaki1,2, Runa Izutsu1
1Division of Experimental Pathology, Faculty of Medicine, Tottori University, 86 Nishicho, Yonago, 683-8503, Japan.
Scientific reports
|September 25, 2025
概括
安福特林诱导的基因和开放式读取框架2 (AMIGO2) 通过促进癌症干细胞的特性来推动癌症的进展. 抑制AMIGO2可以减少瘤生长,并提高胃癌和结肠癌细胞的药物敏感性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 安福特林诱导基因和开放式读取框架2 (AMIGO2) 是已知的肝转移驱动因素.
- AMIGO2表达与癌症患者的预后相关,特别是那些自发性肝转移率低的患者.
研究的目的:
- 为了研究AMIGO2在癌症干细胞类特性的发展中的作用.
- 为了确定AMIGO2是否影响癌细胞增殖,球体形成和耐药性.
主要方法:
- 使用了人类胃 (MKN45) 和结肠 (DLD-1) 癌细胞系.
- 使用短毛RNA (shRNA) 来击败AMIGO2表达.
- 评估了NOD/SCID小鼠的细胞增殖,多细胞球体形成,药物敏感性和体内瘤生长.
主要成果:
- 在饥饿条件下抑制了AMIGO2的细胞增殖,并在3D培养中减少了球形形成.
- 抑制AMIGO2降低了球形细胞中抗癌药物的最大抑制度的一半.
- 沉默AMIGO2抑制了小鼠的瘤形成和生长,与AMIGO2和癌症干细胞标记物的相关表达 (CD44,CD133,EpCAM).
结论:
- AMIGO2通过诱导类似于癌症干细胞的表型来促进人类癌细胞的恶性进展.
- 艾米戈2是克服耐药性和改善癌症治疗结果的潜在治疗标.
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K


